The use of multiparametric MRI scans for the evaluation of men with prostate cancer has increased dramatically and is likely to continue expanding as new developments come to practice. However, it has not yet gained the same level of acceptance of other imaging tests. Partly, this is because of the use of suboptimal protocols, lack of standardization, and inadequate patient preparation. In this manuscript, we describe several practical aspects of prostate MRI that may facilitate the implementation of new prostate imaging programs or the expansion of existing ones.
Multiparametric magnetic resonance imaging (mpMRI) of the prostate combines anatomic with functional and physiological assessment of the gland, and encompasses various sequences, including T1-and T2-weighted MR imaging, diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps, dynamic contrastenhanced (DCE) MRI, and sometimes proton magnetic resonance spectroscopic imaging (1H-MRSI) [1] [2] [3] , as shown in Fig. 1 . As such, in addition to the anatomic data, the mpMRI exam offers information about the microscopic mobility of water (Brownian motion), biochemical characteristics, neovascularity, and cellular structure of the prostatic tissue. Since these characteristics are different for malignant and benign tissues, highresolution mpMRI provides valuable data that helps characterize the extent and biological behavior of prostate cancer. Owing to these capabilities, MR imaging of the prostate is increasingly being used to assist patients and clinicians to make management decisions [4] [5] [6] [7] [8] .
The mpMRI exam offers a comprehensive assessment of prostatic tissues using an array of metrics that can be tailored according to the patient's clinical need. Among the main patient-specific factors that determine optimal mpMRI, performance is the patient treatment history [9] . The imaging metrics most relevant to diagnosis may change for imaging patients after radiation [10, 11] , focal brachytherapy [12] , hormone treatment [13, 14] , and/or surgery [13, 15, 16] . Additionally, implants associated with abdominal and pelvic comorbidities-such as hip replacements [17, 18] or lumbar fusions [19] -can significantly affect image quality for certain modalities. This detrimental effect of implants on MR imaging is changing with increased usage of non-metallic implants [20] . Irrespective of the imaging center's abilities to perform an mpMRI, the individual patient history will dictate the most appropriate imaging metrics to include for diagnosis.
Multiparametric MRI of the prostate, however, is still plagued by lack of standardization, which in turn leads to a heterogeneous performance of the method. In part aiming at this problem, the American College of Radiology (ACR), the European Society of Urogenital Radiology, and the AdMeTech Foundation have proCorrespondence to: Antonio C. Westphalen; email: antonio.westphalen@ucsf.edu posed the use of the Prostate Imaging Reporting and Data System (PI-RADS), now in its second version [3] . In that document, the ACR describes, among other important aspects of mpMRI, the minimum recommended parameters for imaging patients. In this article, we discuss various aspects of imaging acquisition and suggest two protocols that may be used for adequate assessment of patients with prostate cancer.
Hardware and software considerations
Multiparametric prostate imaging was initially implemented on 1.5-Tesla (1.5T) scanners [21] [22] [23] [24] [25] [26] [27] [28] [29] . To acquire scans with diagnostic value, both a pelvic phased array and an endorectal coil (ERC) were used in combination [30] . In prostate MR imaging, ERCs provide a significant improvement in signal-to-noise ratio (SNR) and spatial resolution when compared to pelvic phased array coils alone [31] . This has a profound impact on the quality of the SNR-starved functional imaging, i.e., 1H-MRSI and DWI. Traditional ERCs use a balloon-filled coil that achieves nine-fold SNR improvement over a phased array alone [31] . After insertion into the rectum, the balloon is inflated, with 40-80 ml of either an inert fluid that matches the susceptibility of the prostatic tissues, e.g., perfluorocarbon (PFC) or barium sulfate [31] , or alternatively with air or water. Using an inert fluid instead of air or water improves the homogeneity of the magnetic field and decreases susceptibility artifacts between the rectum and the prostate [32, 33] . These inflatable ERCs provide better coverage, are associated with fewer motion artifacts, and are faster to position when compared to rigid coils [31] . Using either a rigid or an inflatable ERC will create an inhomogeneous reception profile which results in higher signal intensity (SI) near the rectal wall and may hinder cancer detection in the peripheral zone. Fortunately, this signal non-uniformity can be easily rectified using readily available coil-correction software [34] .
The introduction of 3-Tesla (3T) clinical scanners presents an opportunity to enhance image quality by trading the increased SNR for improvements in spatial and temporal resolutions, decreasing the necessity of an ERC. However, the SNR increase provided by an ERC can only be partially replaced by a two-fold SNR improvement associated with doubling the magnet strength. Nevertheless, with advances in pulse sequence design, several groups reported that studies done solely with 6 to 32 phased array surface coils at 3T yielded comparable images as the exams conducted with 1.5T scanners with an endorectal coil [35] [36] [37] [38] [39] . Comparison studies with and without ERC at 3T have shown increased sensitivity (0.45, no ERC and 0.75, with ERC) and positive predictive value (0.64, no ERC and 0.80, ERC) for prostate cancer detection [40] (Fig. 2) . However, considering patient discomfort, patient preparation, costs, coil placement time, and anatomical distortion associated with ERCs, the use of ERCs in prostate imaging is still being actively debated.
Various commercially available and proprietary softwares are used for advanced assessment of MR images. These include software for post-processing of DWI, MRSI, and, most commonly, DCE data. While these technologies are not essential for imaging interpretation, they often improve the workflow in the reading room by optimally displaying the various MR data, which in turn leads to faster analyses, interpretation [41] , and reporting [42] . These systems have also been shown to increase the confidence of less experienced readers [43] . Furthermore, many of these softwares are now used to prepare the MR data for fusion with ultrasound images in MR targeted biopsy systems [44] .
Protocols
Patients are usually scanned in the supine position to maximize patient comfort and minimize respiratory-induced prostate motion between acquisitions. However, when an ERC is not used, the prone position may be a better alternative for some men. Imaging patients in the prone position can result in higher respiratory motion artifacts but may be necessary to facilitate comfort for certain patients [45, 46] . MR imaging of the prostate begins with a low-resolution 3-plane localizer 'scout.' These images are used to locate the prostate and establish the orientation of the coils in relation to the gland prior to scanning. If an endorectal coil is used, then particular attention should be paid to the sagittal scout and axial images, and any adjustments in ERC placement and rotation must be made before time-intensive scanning begins. Guidelines for 3T MRI acquisition parameters based on the protocol used at our institution are summarized in Table 1 (with an ERC) and Table 2 (without an ERC).
T1-weighted MR imaging
A multiparametric MR imaging exam of the prostate typically includes an axial large field-of-view T1-weighted scan of the entire pelvis to assess regional lymph nodes for abnormal size, shape, or intensity. Identification of these lymph nodes is facilitated by the T1 contrast between the high signal intensity of visceral fat and lower signal intensity of large or irregularly shaped lymph nodes [47] . To ensure that lymph nodes in the drainage pathway are imaged during the exam, the T1-weighted scan prescription should extend superiorly to the aortic bifurcation [48] . T1-weighted imaging is also useful to diagnose post-biopsy hemorrhage, which demonstrates high signal intensity [47] . Hemorrhage often has low T2 signal intensity, mimicking cancer, and may introduce significant artifact on DWI and 1H-MRSI, and confound results from DCE MR imaging. For this reason, an interval of at least 6 weeks between the most recent prostate biopsy and the MRI scan is recommended [49, 50] . In addition, these T1-weighted images offer an opportunity to detect osseous metastases. While lesions will be incompletely assessed with a single sequence, after correlation with clinical history and histology, further diagnostic steps may be taken.
T2-weighted MR imaging
Multiplanar high-resolution two-dimensional (2D) fast spin-echo (FSE) T2-weighted MR images provide ex- quisite soft-tissue contrast and excellent depiction of zonal anatomy, and are the backbone of MR imaging of the prostate. The majority of prostate cancers are adenocarcinomas that arise within the peripheral zone. Most have low signal intensity against the background of the bright peripheral zone tissue. Transitional zone tumors represent most of the remaining prostate cancers. Similarly to peripheral zone cancers, these lesions usually have low signal intensity on T2-weighted MR images but can be difficult to distinguish from benign tissue, in particular in the presence of benign prostatic hyperplasia (BPH). T2-weighted MR imaging is also the main sequence utilized to assess locoregional spread of cancer [51, 52] ; the diagnostic accuracy, though, is higher when it is combined with other functional sequences [53] .
Prognosis, management, and treatment options of prostate cancer are greatly affected by cancer stage, in particular by the presence of extracapsular extension (ECE) and/or seminal vesicle invasion (SVI).
High-resolution 2D FSE T2-weighted images are acquired in the true sagittal plane, as well as the oblique axial ( Fig. 1A ) and oblique coronal planes of the prostate [54] . It is recommended that the slice thickness should not be more than 3 mm, without a gap, and the in-plane dimension of £0.7 mm (phase) x £ 0.4 mm (frequency). For most patients, a field-of-view of 12-18 cm will allow for the inclusion of the entire gland and seminal vesicles. High-resolution 3D FSE T2-weighted MR imaging has emerged as a promising technique that allows for the acquisition of isotropic images and may coil. This patient was scanned twice in 3 months in anticipation of the MR-guided biopsy. We observe a noticeably increased noise in the image without an ERC, as well as diminished delineation between nodules inside the gland. save time by reducing the number of sequences that need to be obtained. However, the quality of the 3D sequence may be limited if acquired on older or low-field magnets due to the need for thinly sliced images for adequate reformatting. While the T2 contrast is not the same as seen in 2D acquisitions, it is clinically acceptable [55] . Data of a study by Westphalen et al. showed that the preference for the 2D or 3D FSE MR images varies widely among radiologists, but without differences in their ability to delineate the anatomy and identify cancer [56] . This same study did find differences in image sharpness and the presence of some artifacts. The 2D FSE images were sharper than the 3D ones but demonstrated more artifacts (Fig. 3 ).
Diffusion-weighted MR imaging
DWI exploits the random motion of water molecules in biological tissues (Brownian motion) to characterize disease. These images are primarily utilized to calculate ADC maps (Fig. 1C) . The glandular structure of the normal peripheral zone of the prostate compared to the shrunken glands or tightly packed cancerous tissue defines a well-established contrast between healthy and tumor tissue on DWI and the corresponding ADC maps [57] . Perhaps not surprisingly, DWI has been shown to increase the sensitivity and specificity of multiparametric MR imaging for the detection of prostate cancer [58] [59] [60] . It has also been shown to improve the assessment of tumor aggressiveness when combined with conventional T2-weighted imaging, with an inverse relationship between the apparent diffusion coefficient (ADC) map intensity and the Gleason score [61] . A threshold of approximately 850 9 10 -6 mm 2 /s has been used to distinguish between low-and high-grade tumors [62] . Yet, because of substantial overlap of ADC values seen in BPH and cancers, and variability across the various imaging platforms and due to different acquisition parameters, a qualitative visual assessment may be preferred.
Adequate characterization of the random motion of water requires information about its movement in multiple directions. Accordingly, DWI usually comprised at least three separate acquisitions, each measuring diffusion in a different direction. Due to this unique sequence structure, DWI is particularly prone to artifact from patient motion between directional acquisitions. To mitigate this problem, images are usually acquired with an echo-planar imaging (EPI) pulse sequence, designed to decrease scan time.
For prostate cancer detection on 3T scanners, the bvalues are generally divided into mid (between 500 and 800 s/mm 2 ) and high (between 1000 and 2500 s/mm 2 ) (Fig. 1D) [63, 64] . Scanning on older magnets usually excludes b-values above 1000 s/mm 2 due to limits in gradient hardware. Using a lower b-value emphasizes extracellular effects in the resulting ADC maps, whereas using a high b-value emphasizes intracellular motion. Recently, it has become popular to utilize more than one b-value for the assessment of prostate cancer. Imaging with a mid-range b-value will normally have a greater SNR, which can result in finer resolution and a decreased number of signal averages per image. However, a high bvalue acquisition reduces the signal from normal prostatic tissue, increasing the sensitivity to abnormal cellular environments [65] . One method of gaining the advantage of contrast of a high b-value while still having the high SNR and fine resolution of a lower b-value acquisition is to extrapolate and compute the theoretical image output for higher b-values [66] . These images show higher SNR than traditional DWI collected with the equivalent high b-values and can be utilized on older 1.5T scanners where gradient hardware may not allow acquisition with high b-values [67] .
In addition to more heavily diffusion-weighted images, a low b-value image is acquired with a b-value in the range of 0-100 s/mm 2 [68] . This image serves as a reference, to fit a slope to the signal per b-value per direction, which is combined to define the ADC map. The lower b-values are also used because they remove the effect of perfusion on the resulting ADC map.
In order to easily associate structural T2-weighted images with functional DWI data, DWI should be performed with the same or similar slice thickness and acquisition prescription to high-resolution T2-weighed imaging. DWI can be performed immediately after T2-weighted imaging to increase structural similarity.
DWI is heavily affected by susceptibility artifacts, which increase in magnitude with higher field strength [69] . Images acquired with EPI, in particular, suffer from severe susceptibility artifact at the interfaces of tissue with air, blood, or fecal matter in the rectum. These artifacts are important because they present at the border of the rectum and affect the peripheral zone of the prostate, where 70% of cancers are located [70] . Performing a rectal enema before the exam reduces susceptibility artifact from air or fecal matter in the rectum [71, 72] . A promising recent development for artifact reduction is reduced field-of-view imaging, which has been shown to improve image quality and contrast between tumor and healthy tissue, as well as to decrease susceptibility artifact in prostate DWI [73] (Fig. 4) .
Two novel methods that may improve the characterization of prostate cancer are diffusion kurtosis (DK), which examines non-Gaussian water behavior at high bvalues [74] , and whole-lesion histogram analysis, which samples every voxel within a 3D region of interest [75] . While initial studies are promising, both require dedicated post-processing software for analysis and are currently exploratory techniques not suitable for use at most clinical sites (Fig. 5) .
Dynamic contrast-enhanced imaging
Dynamic contrast-enhanced imaging follows the time course of tissue enhancement post contrast agent injec- the rFOV method for distinguishing boundaries of the prostate and BPH nodules within the prostate. We also see susceptibility artifact from fecal matter or air in the rectum, which significantly blurs the rectal wall on (C) and less so on (B).
tion to evaluate the properties of tissue microstructure and neovascularity. Prostate cancer brings about changes in the cellular structure of the tissues, which result in altered interactions of the tissues with the injected contrast. It is believed that MR contrast agents do not reach the lumen of the healthy glandular tissues [76, 77] . Conversely, prostate cancer is marked by the loss of the basement membrane outside the glandular epithelial cells, which allows the contrast to enter the glands, resulting in a greater and faster tissue enhancement seen in DCE studies. In addition to continuing alterations in tissue microstructure, prostate cancer progression is also associated with neoangiogenesis [78] [79] [80] [81] [82] . The rapid growth and division of tumor vasculature result in disorganized, irregularly shaped, immature vessels [83] [84] [85] . DCE takes advantage of the unique characteristics associated with the abnormal tumor vasculature to assess aggressiveness of the disease. The usefulness of DCE in detecting, localizing, and staging prostate cancer is well documented in literature [58, [86] [87] [88] [89] [90] . Additionally, several studies have reported promising findings on the utility of DCE parameters in discriminating prostate cancer based on aggressiveness of the disease [91, 92] . While DCE is an invaluable sequence in certain instances where other acquisition sequences will show artifact (i.e., for patients with hip replacements), DCE results might be confounded by the presence of prostatitis in the peripheral zone [1, 5, 93] or by mixed BPH nodules in the central gland [1, 5, 94, 95] .
DCE imaging is often done with a 3D Fast Spoiled Gradient Echo (3D-FSPGR) pulse sequence. T1-weighted images are collected before, during, and after administration of a contrast agent. A DCE scan is often preceded by a T1 mapping, a measurement of the native tissue relaxation time (T10) obtained using a series of volume acquisitions with variable flip angle values. Once the native T1 mapping is complete, several pre-contrast dynamic T1-weighted volumes are acquired to establish a baseline. The contrast agent is administered as an intravenous bolus at a rate of 2-4 ml/s followed by a 20-ml saline flush using a power injector. To ensure patient safety, patient's kidney function should be evaluated prior to contrast injection. Estimated glomerular filtration rate (eGFR) based on the blood creatinine levels are often used as indicators of kidney health. Once injected, the contrast agent does not penetrate the healthy prostate glands but collects in the extravascular extracellular space (EES), where it serves to shorten local relaxation times, producing high signal intensity on T1-weighted images. The contrast is cleared from the blood via renal excretion.
DCE-MRI studies typically utilize weight-adjusted (0.1 mmol/kg of body weight) paramagnetic gadolinium chelate contrast agents. There are several agents approved by the United States Food and Drug Administration, including gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), or gadodiamide (Omniscan) [96] . Aiming for a reasonable spatiotemporal resolution, a five-minute DCE acquisition yields dynamic imaging with a temporal resolution in the range of 3-10 s, a spatial resolution in the range of 0.7 9 0.7 mm to 1.9 9 1.9 mm with a slice thickness of 3-4 mm [27, 66, 91, 92, 95, [97] [98] [99] [100] [101] . Compressed sensing techniques have been implemented into DCE sequences to improve spatiotemporal resolution or increase the coverage. Recently, Rosenkrantz et al. reported the use of a highspatiotemporal resolution DCE technique GRASP (Golden-angle Radial Sparse Parallel), which allows for image acquisition with spatial resolution of 1.1 9 1.1 9 3.0 mm and temporal resolution of 2.3 s [102] .
Tissue enhancement observed during DCE can be interpreted either by visually inspecting the raw images (qualitative approach) or by using semi-quantitative or quantitative methods [103] [104] [105] [106] . The qualitative analysis of the DCE images [107] [108] [109] is based on the premise that the blood vessels recruited by the prostate tumors are leaky [110, 111] . When the contrast is injected, the cancerous tissues demonstrate early and rapid enhancement followed by a quick washout, which is noticeably different from a slow and steady enhancement observed for normal tissues. An observer may evaluate regions of interest within the prostate by categorizing the overall enhancement as 1) persistent-a steady enhancement, usually indicative of benign pathology, 2) plateau-the initial uptake is followed by a constant enhancement, slightly suspicious for malignancy, and 3) washout-a sharp uptake is followed by a steep washout, strongly suspicion for malignancy (Fig. 6) . While the qualitative approach is quick and intuitive, it fails to comprehensively assess heterogeneous tissues and is inherently subjective and difficult to standardize among imaging centers. Semi-quantitative analysis characterizes the enhancement curve on a voxel by voxel basis by calculating curve parameters such as maximum enhancement slope (Fig. 1E) , time to peak, peak enhancement, washout slope (Fig. 1F) , and area under the curve [92, 112] . Although this approach is extensively used in the assessment of DCE-MRI, the semi-quantitative parameters provide little physiologic insight into behavior of the tumor vessels and the usefulness of the computed metrics can be limited when comparing data across different imaging protocols. Normalization to muscle has been suggested to aid in generalization of semi-quantitative parameters [76] .
The final approach to analyzing DCE images aims to estimate physiologically interpretable, kinetic parameters by fitting pharmacokinetic models to the enhancement curves [88, 113, 114] . The most common is the two-compartment model. The two compartments are the plasma space of the vasculature and the interstitial space between the prostate cells. The two main parameters derived from such models are K trans (the volume transfer constant between plasma and extracellular space, expressed in units of min
) and v e (the fractional volume of extracellular space per unit volume of tissue) [90, [115] [116] [117] [118] . While K trans maps offer diagnostically valuable information, acquiring stable measurements from quantitative analysis remains a challenge. Quantitative methods are affected by a number of variables such as changes in cardiac output, accurate tissue T1, and arterial input function (AIF) measurements, as well as the underlying assumptions made by the software packages. Accuracy of T1 measurements is greatly aided by T1 mapping [119] . Ideally, the AIF (the concentration of the contrast agent in the feeding blood supply) is measured for each individual patient in the femoral artery [120] [121] [122] . Unfortunately, in a clinical setting, the required temporal resolution may be difficult to achieve. A common approach is to use a population-averaged AIF in the form of a bi-exponential decay [97] . Finally, there are several open-source and commercially available software packages for both clinical and preclinical quantitative DCE analyses [123] [124] [125] [126] [127] . However, a few studies have been done to assess reproducibility of pharmacokinetic measurements obtained with different software packages.
The recently released second version of PI-RADS highlights the fact that DCE-MRI can be and is most widely assessed based on direct visualization of the raw data; optional tools, e.g., parametric maps and compartmental models, can be used to assist in diagnosis, but findings should always be confirmed on source images [3] . Last but not least, PI-RADS v2 characterizes a positive finding on DCE-MRI as a lesion with focal enhancement, earlier or contemporaneous with enhancement of adjacent normal tissues, and that corresponds to a suspicious finding on T2-or diffusionweighted MR images.
Proton magnetic resonance spectroscopic imaging
Proton magnetic resonance spectroscopic imaging is a technique used to study in vivo cellular metabolism and has been established as a powerful technique for assessing patients with prostate cancer. Benign and malignant tissues can be differentiated based on the metabolic changes associated with prostate cancer [128, 129] . Normal prostatic glandular epithelial cells produce and secrete high levels of citrate (2.5-2.7 ppm) [130, 131] . Prostate cancer disrupts the epithelial tissues and triggers a metabolic shift from citrate production to citrate oxidation; the overall effect is a substantial reduction in citrate levels in malignant prostate tissues [132] [133] [134] (Fig. 5) . Furthermore, increased cell density and elevated cell membrane turnover lead to increased levels of choline (3.21 ppm) in prostate cancer [135] [136] [137] (Fig. 1B) . Creatine (3.02 ppm) is another metabolite of interest; it is maintained at a relatively constant level in both healthy and malignant prostatic tissues and serves as an internal Ref. [134] . Lastly, some groups found it informative to track metabolic changes associated with polyamine [129] . Polyamines (especially spermine) are found in healthy prostate epithelial cells, and similar to citrate, their levels are dramatically reduced in prostate cancer [138] .
Due to the multifocal nature of prostate cancer, a high-resolution metabolic mapping of the entire prostate is required for accurate cancer localization and diagnosis. The 1H-MRSI acquisition has evolved from singlevoxel spectroscopy to 3D 1H-MRSI that is typically acquired using phase encoding in all three directions but is time consuming. Improvements in pulse sequence design have enabled the acquisition of metabolic information from the entire prostate at high resolution within less than 10 min with voxel sizes ranging from 0.2 to 0.5 cm 3 , making 1H-MRSI a clinically feasible technique [139, 140] . These include using flyback echo-planar readout gradients to improve efficiency and robustness to errors and non-uniform undersampling, and compressed sensing to accelerate the acquisition [141, 142] . A number of techniques have been used to reduce the negative effects of periprostatic fat, including outer volume saturation (OVS) with very selective suppression (VSS) pulses [143] , band selective inversion with gradient dephasing (BASING) [144, 145] , and spectral-spatial radiofrequency pulses [146, 147] .
The 1H-MRSI sequence is usually prescribed off the axial T2-weighted MR images with a volume selected to maximally cover the prostate while excluding the seminal vesicles, periprostatic fat, and as much of the rectum as possible. Standard post-processing involves zero-filling, apodization using Gaussian or Lorentzian filtering, and Fourier transform of the free induction decay signal, as well as baseline and phase corrections [148] [149] [150] [151] .
Interpretation of 1H-MRSI data is often done on a voxel-by-voxel basis, which can be time consuming and introduce interobserver variability. An alternative approach to review these metabolites is to observe peak area ratios, such as the choline + creatine to citrate ratio within each voxel: choline and creatine are typically combined due to signal overlap. In 2004, Jung et al. proposed a standardized scoring system for peripheral zone tissues based on metabolic data, ranging from 1 (definitely normal) to 5 (definitely cancer) [152] . And in 2007, Futterer et al. introduced standardized thresholds for differentiation of benign and malignant tissues in the peripheral zone and central gland of the prostate [153] . Several studies reported significant correlations between peak area ratios and Gleason scores [154, 155] ; yet, interpretation can be hindered by choline contamination from the seminal vesicles or urethra [134, 156] or by prostatitis [157, 158] , which can result in false positive findings.
It is also important to note that the data of some studies were unfavorable to the clinical usefulness of 1H-MRSI, more notoriously those of the ACRIN 6659 study published by Weinreb et al. that found no incremental benefit for 1H-MRSI compared with MRI alone in sextant tumor localization [29] . Based on such data, and possibly on the complexity of imaging acquisition and interpretation, 1H-MRSI, which was an optional tool in the initial version of PI-RADS, no longer influences the assessment of lesion in PI-RADS v2.
Patient preparation
We have anecdotally noted that providing patients with information detailing the procedure and the required preparation prior to the exam improves patient compliance. Patients with severe claustrophobia may be required or advised to bring prescription sedatives to the exam. In some centers, antispasmodic agents like butylscopolamine are administered immediately prior to scanning to decrease bowel peristalsis and potential artifacts related to motion. However, peristaltic suppression is controversial, as some groups have failed to identify a significant improvement of image quality in studies performed on 3T scanner without an ERC [159] [160] [161] . Patients undergoing scans with an ERC should be advised to perform a saline laxative enema within a 3-h window of the exam to facilitate proper endorectal coil placement and minimize susceptibility artifacts associated with air or fecal contamination. Enemas are not required prior to scans done without an ERC, though, as the improvement in image quality is at best marginal [162] . Some imaging facilities also recommend patients to abstain from ejaculating 1-3 days prior to the MR scan in order to maintain distention of the seminal vesicles and increase conspicuity of possible tumor invasion. The validity of this claim, however, has not been tested. In a pilot study, Medved et al. reported decreased signal intensity on T2-weighted imaging and the apparent diffusion coefficient maps in the peripheral zone after ejaculation, possibly reflecting a reduction in the volume of ejaculatory fluid within the gland [163] . The authors did not observe any dramatic differences in image quality or significant changes in prostate volume after ejaculation. Since the study was done in healthy volunteers, the effect of ejaculation on prostate cancer diagnosis has not been established.
Conclusion
Use of mpMRI exams for the diagnosis and staging of prostate cancer has become prominent at medical centers around the world [164] [165] [166] and is likely to continue expanding into increasing modalities in the age of precision medicine. However, mpMRI of the prostate did not yet gain the same level of acceptance of other imaging tests; and this is at least in part due to the use of suboptimal protocols, lack of standardization, and inadequate patient preparation. The American College of Radiology, in conjunction with the European Society of Urogenital Radiology and the AdMeTech Foundation, has developed standards for the Prostate Imaging Reporting and Data System (PI-RADS) [3] . Currently, in its version number 2, in addition to providing guidelines for interpretation and reporting of mpMRI, PI-RADS establishes the minimum acceptable technical parameters for scanning patients. Finally, regardless of the magnet strength, the use of an endorectal coil, or the details of the imaging protocol, patient preparation is essential to acquiring the highest quality images while maintaining maximal patient comfort and compliance. Equally important in providing the best imaging exam for patient diagnosis is the communication between primary physicians, radiologists, researchers, and staff.
